Zeng Li Selected Research

Zeng Li Research Topics

Disease

16	Neoplasms (Cancer) 10/2022 - 06/2010
11	Inflammation (Inflammations) 01/2022 - 01/2016
8	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2013
6	Osteoarthritis 09/2020 - 02/2018
4	Arthritis (Polyarthritis) 08/2022 - 01/2021
4	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2018
4	Infections 08/2021 - 01/2019
4	Acute Kidney Injury (Acute Renal Failure) 10/2020 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2014
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 03/2014
2	Venous Thromboembolism 08/2022 - 01/2021
2	Hemorrhage 08/2022 - 01/2021
2	Experimental Arthritis 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021 - 09/2016
2	Cognitive Dysfunction 01/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2017
2	Rheumatoid Arthritis 09/2020 - 02/2017
2	Osteonecrosis (Kienbock's Disease) 03/2020 - 10/2019
2	Necrosis 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 07/2018 - 05/2010
2	Carcinogenesis 07/2018 - 01/2012
1	Wounds and Injuries (Trauma) 08/2022
1	Neuroinflammatory Diseases 01/2022
1	Ischemia 01/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Parasitemia 08/2021
1	Central Nervous System Diseases (CNS Diseases) 06/2021
1	Ductal Carcinoma 01/2021
1	COVID-19 01/2021
1	Hemophilia A (Haemophilia) 09/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Neuroma 11/2019

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 01/2022 - 06/2016
6	Biological ProductsIBA 01/2022 - 09/2013
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2014
6	CytokinesIBA 06/2021 - 02/2017
4	hesperetinIBA 06/2021 - 06/2017
4	Pharmaceutical PreparationsIBA 03/2021 - 09/2012
4	MicroRNAs (MicroRNA)IBA 03/2020 - 01/2012
3	Therapeutic UsesIBA 01/2022 - 01/2019
3	EnzymesIBA 08/2021 - 02/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2016
3	Circular RNAIBA 03/2020 - 10/2019
2	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 01/2021
2	CateninsIBA 01/2022 - 01/2021
2	Collagen Type II (Type II Collagen)IBA 01/2022 - 01/2021
2	rutecarpineIBA 01/2022 - 10/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2021
2	7-hydroxycoumarin (umbelliferone)IBA 01/2022 - 04/2020
2	paeonolIBA 05/2021 - 02/2021
2	Scopolamine (Hyoscine)FDA Link 01/2021 - 01/2021
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2020
2	Long Noncoding RNAIBA 10/2019 - 07/2018
2	Amyloid beta-PeptidesIBA 02/2018 - 11/2013
2	wogoninIBA 01/2018 - 10/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 04/2016
2	matrigelIBA 05/2017 - 03/2014
2	quindolineIBA 01/2017 - 06/2010
2	QuinazolinesIBA 06/2016 - 10/2014
1	quinolineIBA 08/2022
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	ButyrylcholinesteraseIBA 01/2022
1	6-methyladenineIBA 01/2022
1	HomocysteineIBA 01/2022
1	AntigensIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2021
1	VaccinesIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2021
1	Trace Elements (Biometals)IBA 01/2021
1	IonsIBA 01/2021
1	Aquaporin 1IBA 01/2021
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2021
1	RivaroxabanIBA 01/2021
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	Cycloheximide (Cicloheximide)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	HMGB1 Protein (HMG1)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	PSMA-1007IBA 01/2020
1	Recombinases (Recombinase)IBA 01/2020
1	Mitochondrial Permeability Transition PoreIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 01/2020

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2012
3	Aftercare (After-Treatment) 12/2021 - 04/2016
3	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2020 - 06/2019
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2021
1	Duration of Therapy 09/2020